Rheumatoid arthritis in the elderly: Characteristics and treatment considerations

被引:177
作者
Serhal, Lina [1 ,2 ]
Lwin, May N. [1 ,2 ]
Holroyd, Christopher [1 ]
Edwards, Christopher J. [1 ,2 ]
机构
[1] Univ Hosp Southampton NHS Fdn Trust, Dept Rheumatol, Southampton, Hants, England
[2] Univ Hosp Southampton NHS Fdn Trust, NIHR Clin Res Facil, Southampton, Hants, England
关键词
Rheumatoid arthritis; Elderly onset; Elderly; Biological age; Comorbidities; Treatment; MODIFYING ANTIRHEUMATIC DRUGS; NECROSIS-FACTOR INHIBITORS; INTERSTITIAL LUNG-DISEASE; CONGESTIVE-HEART-FAILURE; GERIATRIC SYNDROMES; COGNITIVE FUNCTION; SERIOUS INFECTION; FRENCH SOCIETY; IMMUNE-SYSTEM; RISK-FACTORS;
D O I
10.1016/j.autrev.2020.102528
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
071005 [微生物学]; 100108 [医学免疫学];
摘要
The elderly rheumatoid arthritis (RA) population consists of both elderly-onset RA that manifests after the age of 60 and individuals diagnosed with RA early in life who age naturally to become members of this group. The elderly RA population is expanding due to both increased life expectancy and an increased incidence of elderly onset RA. Elderly onset RA seems to have a characteristic clinical pattern and perhaps biological profile different to that of early onset RA. The management of RA in elderly patients can be challenging, as robust treat-to-target approaches must be balanced against the adverse events due to increased comorbidities in old age. This produces a tendency to prefer less aggressive treatment in elderly RA patients in clinical practice. Despite the concerns about adverse events, there is limited evidence on the best way to approach RA in this population, as elderly patients are often not well presented in the clinical trials. Herein, we review the literature to assess the efficacy and safety of RA therapies in this age group. We then suggest a tailored approach that can be adopted in clinical practice, based on the disease severity and risk profiles of elderly RA patients.
引用
收藏
页数:8
相关论文
共 95 条
[1]
Role of inflammation in the aging bones [J].
Abdelmagid, Samir M. ;
Barbe, Mary F. ;
Safadi, Fayez F. .
LIFE SCIENCES, 2015, 123 :25-34
[2]
Age at menarche in Canada: results from the National Longitudinal Survey of Children & Youth [J].
Al-Sahab, Ban ;
Ardern, Chris I. ;
Hamadeh, Mazen J. ;
Tamim, Hala .
BMC PUBLIC HEALTH, 2010, 10
[3]
[Anonymous], ARTHRITIS RHEUMATOL
[4]
[Anonymous], ACR ARHP ANN M OCT 2
[5]
[Anonymous], AD SMOK HAB UK 2018
[6]
Occurrence and risk factors for falls in rheumatoid arthritis [J].
Armstrong, C ;
Swarbrick, CM ;
Pye, SR ;
O'Neill, TW .
ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (11) :1602-1604
[7]
The Impact of Traditional Cardiovascular Risk Factors on Cardiovascular Outcomes in Patients with Rheumatoid Arthritis: A Systematic Review and Meta-Analysis [J].
Baghdadi, Leena R. ;
Woodman, Richard J. ;
Shanahan, E. Michael ;
Mangoni, Arduino A. .
PLOS ONE, 2015, 10 (02)
[8]
The effect of biological DMARDs on the risk of congestive heart failure in rheumatoid arthritis: a systematic review [J].
Baniaamam, Milad ;
Paulus, Walter J. ;
Blanken, Annelies B. ;
Nurmohamed, Michael T. .
EXPERT OPINION ON BIOLOGICAL THERAPY, 2018, 18 (05) :585-594
[9]
Bathon JM, 2006, J RHEUMATOL, V33, P234
[10]
A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis [J].
Bathon, JM ;
Martin, RW ;
Fleischmann, RM ;
Tesser, JR ;
Schiff, MH ;
Keystone, EC ;
Genovese, MC ;
Wasko, MC ;
Moreland, LW ;
Weaver, AL ;
Markenson, J ;
Finck, BK .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (22) :1586-1593